|
2025
|
P/S
|
Printed educational materials in the field of pharmaceutical and cardiovascular disease Medical b... |
|
|
P/S
|
pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions... |
|
|
P/S
|
Pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions... |
|
|
Invention
|
Methods of treating heart failure with cardiac sarcomere activators.
Provided herein are methods... |
|
|
Invention
|
Fast skeletal muscle myosin inhibitors. Provided are compounds of Formula (I): Also provided is a... |
|
|
Invention
|
Cardiac sarcomere inhibitors.
Provided are compounds of Formula (I):
Provided are compounds of... |
|
2024
|
Invention
|
Methods for treating heart diseases.
Provided herein are methods of treating patients by adminis... |
|
|
Invention
|
Methods for treating heart diseases. Provided herein are methods of treating patients by administ... |
|
|
Invention
|
Salt of omecamtiv mecarbil and process for preparing salt.
Provided are omecamtiv mecarbil dihyd... |
|
|
Invention
|
Methods of treating heart failure by administering omecamtiv mecarbil.
Provided herein are metho... |
|
|
Invention
|
Methods for treating hypertrophic cardiomyopathy.
Methods for treating obstructive hypertrophic ... |
|
|
Invention
|
Methods for treating hypertrophic cardiomyopathy. Methods for treating obstructive hypertrophic c... |
|
|
P/S
|
Downloadable electronic publications, namely, newsletters in the field of hypertrophic cardiomyop... |
|
|
P/S
|
Downloadable electronic publications, namely, newsletters, speaker communications in the nature o... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiovascular, heart and muscle diseases and di... |
|
|
Invention
|
Treatment of heart failure with dosage regimens of omecamtiv mecarbil. Methods for treating heart... |
|
|
P/S
|
pharmaceutical preparations for human use, namely medications to treat cardiovascular conditions;... |
|
|
Invention
|
Bicyclic 1,4-diazepanones and therapeutic uses thereof. Provided herein are compounds of formula ... |
|
|
Invention
|
Cardiac sarcomere inhibitors. Provided are compounds of Formula (I):
5 are as defined herein. Al... |
|
|
P/S
|
pharmaceutical preparations for the treatment of cardiovascular diseases and disorders |
|
|
Invention
|
Cardiac sarcomere inhibitors. Provided are compounds of Formula (I):
4 are as defined herein. Al... |
|
|
Invention
|
Salts and crystal forms of omecamtiv mecarbil.
Provided herein are free base crystalline forms, ... |
|
2023
|
Invention
|
Nampt modulators.
Provided are compounds of Formula (I):
Provided are compounds of Formula (I)... |
|
|
Invention
|
Nampt modulators. Provided are compounds of Formula (I): or a pharmaceutically acceptable salt th... |
|
|
Invention
|
Heterocyclic compounds and their uses. Provided are certain pharmaceutical formulations of omecam... |
|
|
Invention
|
Salt of omecamtiv mecarbil and process for preparing salt. Provided are omecamtiv mecarbil dihydr... |
|
|
Invention
|
Synthesis of reldesemtiv. Provided herein is a process for the preparation of reldesemtiv and sal... |
|
|
Invention
|
Process for preparing aficamten. Provided herein is a process for the preparation of (R)—N-(5-(5-... |
|
|
Invention
|
Crystalline forms of 5-(3,4-difluorobenzyl)-8-((1r,4r)-4-methylcyclohexyl)-6,9-dioxo-2,5,8-triaza... |
|
|
Invention
|
Bisamide sarcomere activating compounds and uses thereof.
The present invention provides a compo... |
|
|
Invention
|
Indane and coumaran derivatives as fast skeletal muscle myosin inhibitors. Provided are compounds... |
|
|
Invention
|
Methods for treating obstructive hypertrophic cardiomyopathy.
Methods for treating symptomatic o... |
|
|
Invention
|
Methods for treating obstructive hypertrophic cardiomyopathy. Methods for treating symptomatic ob... |
|
|
Invention
|
Methods for treating non-obstructive hypertrophic cardiomyopathy.
Methods for treating non-obstr... |
|
|
Invention
|
Methods for treating non-obstructive hypertrophic cardiomyopathy. Methods for treating non-obstru... |
|
|
Invention
|
Methods for treating heart failure by administering cardiac sarcomere activators. Methods for tre... |
|
|
Invention
|
Slow skeletal troponin activators. Provided herein are compounds of Formula (I) and pharmaceutica... |
|
|
Invention
|
Methods of treating heart failure with cardiac sarcomere activators. Provided herein are methods ... |
|
|
Invention
|
Bicyclic piperazinones and therapeutic uses thereof.
Provided herein are compounds of formula (I... |
|
|
Invention
|
Bicyclic piperazinones and therapeutic uses thereof. Provided herein are compounds of formula (I)... |
|
|
P/S
|
Pharmaceutical preparations for human use, namely medications to treat cardiovascular conditions;... |
|
|
P/S
|
Human pharmaceuticals for the treatment of cardiovascular diseases, pulmonary diseases, pulmonary... |
|
|
P/S
|
Printed materials, namely, newsletters in the field of cardiovascular diseases and conditions, sp... |
|
2022
|
Invention
|
Tetrahydroisoquinoline derivatives.
Novel tetrahydroisoquinoline derivative compounds are disclo... |
|
|
Invention
|
Cardiac sarcomere inhibitors. Provided are compounds of Formula (I):
3 are as defined herein.
... |
|
|
Invention
|
Process for preparing aficamten. Provided herein is a process for the preparation of (R)-N-(5-(5-... |
|
|
Invention
|
Cd38 modulators and methods of use thereof.
Provided is a compound of formula (I):
Provided is... |
|
|
P/S
|
Human pharmaceuticals for the treatment of neurological and musculoskeletal diseases and conditio... |
|
|
Invention
|
Amino-pyrimidine skeletal muscle modulators.
Provided are compounds of Formula I:
Provided are... |
|
|
P/S
|
human pharmaceuticals for the treatment of pulmonary diseases, pulmonary conditions, bronchoconst... |
|
|
P/S
|
human pharmaceuticals for the treatment of cardiovascular diseases, diseases and conditions assoc... |
|
2021
|
Invention
|
Pyrazole derivatives useful as nampt modulators.
Provided herein are compounds of formula (A): o... |
|
|
Invention
|
Nampt modulators.
Provided are compounds of Formula (II): or a pharmaceutically acceptable salt ... |
|
|
Invention
|
Nampt modulators.
Provided are compounds of Formula (II) or a pharmaceutically acceptable salt t... |
|
2020
|
P/S
|
Pharmaceutical preparations, pharmaceutical preparations for the treatment of cardiovascular dise... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparat... |
|
2019
|
P/S
|
human pharmaceuticals for the treatment of neurological diseases and conditions, neuromuscular di... |
|
2014
|
P/S
|
Pharmaceuticals. Computer software used in the collection, analysis and presentation of medical, ... |
|
|
P/S
|
Human pharmaceuticals for the treatment of cardiovascular diseases, [ pulmonary diseases, pulmona... |
|
2009
|
P/S
|
Pharmaceutical preparations, namely, human pharmaceuticals for the treatment of cancers, cardiova... |
|
|
P/S
|
[ Technical consulting and ] research in the field of cellular assay screening and pharmaceutical... |
|
|
P/S
|
Pharmaceutical and veterinary preparations, namely, human and veterinary pharmaceuticals for the ... |
|
|
P/S
|
Pharmaceutical and veterinary preparations; human and veterinary pharmaceuticals for the treatmen... |
|
|
P/S
|
Human pharmaceuticals for the treatment of neurological diseases and conditions, neuromuscular di... |
|
2003
|
P/S
|
Oncologic, cardiovascular, infectious disease, neurologic, anti-inflammatory, and ophthalmologica... |
|
1999
|
P/S
|
Consultation and research services relating to drug discovery. |
|
|
P/S
|
Consultation and collaboration relating to drug discovery and patient diagnosis; scientific resea... |
